Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
17 dividend-stock bargains from a value manager with a stellar track record
12:11pm, Tuesday, 02'nd Dec 2025
John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”
Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules
04:48pm, Monday, 01'st Dec 2025
A U.S. judge on Monday rejected Bristol Myers Squibb's bid to dismiss a $6.7 billion lawsuit claiming it cheated shareholders of the former Celgene by delaying federal approval for three drugs, includ
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
10:42am, Monday, 01'st Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
What Is Happening With BMY Stock?
09:50am, Monday, 01'st Dec 2025
Bristol Myers Squibb (BMY) is finally showing signs of life. The stock has climbed 7.3% over the last five days, adding roughly $7 billion in market value — pushing its market cap back toward $100 b
Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio
06:59am, Monday, 01'st Dec 2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASH--Bristol Myers Squibb Data at ASH 2025 Showcases Potential of Hematology Pipeline and Builds Momentum for Next Generation Portfolio.
2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
09:05pm, Sunday, 30'th Nov 2025
Drug companies face fairly normal industry dynamics that can leave them unloved on Wall Street over short periods of time. Pfizer is facing a patent cliff and is making a big move to revamp its drug p
2 Top Dividend Stocks to Buy and Hold
04:05am, Sunday, 30'th Nov 2025
Bristol Myers Squibb and Johnson & Johnson have had a tough past few years due to several factors. Both companies are looking to right the ship thanks to new product launches.
Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend?
06:18am, Saturday, 29'th Nov 2025
Bristol Myers has struggled to generate growth in recent years. Its high debt load has come down but remains a burden for the business.
Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of “Hold” by Brokerages
01:38am, Saturday, 29'th Nov 2025
Shares of Bristol Myers Squibb Company (NYSE: BMY - Get Free Report) have earned an average recommendation of "Hold" from the nineteen brokerages that are presently covering the stock, Marketbeat.com
8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills
11:00am, Friday, 28'th Nov 2025
Eight of the top fifteen Barron's Better Bets (BBB) 'Safer' dividend stocks, including Conagra, Altria, and Verizon, are currently attractively priced for income investors. Analyst forecasts project n
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?
09:36am, Friday, 28'th Nov 2025
GILD's HIV strength, new approvals, and rising estimates set it apart as it edges past a challenged rival in growth prospects.
Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?
02:41pm, Thursday, 27'th Nov 2025
Bristol Myers strengthens its Opdivo franchise with rising demand and strong uptake of Qvantig, leveraging label expansions to sustain revenue growth.
BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Revised)
04:46am, Thursday, 27'th Nov 2025
Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.
Bristol Myers Squibb to Participate in Citi's 2025 Global Healthcare Conference
06:59am, Wednesday, 26'th Nov 2025
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in Citi's 2025 Global Healthcare Conference.
Associated Banc Corp Has $3.99 Million Stock Position in Bristol Myers Squibb Company $BMY
05:38am, Wednesday, 26'th Nov 2025
Associated Banc Corp lowered its stake in Bristol Myers Squibb Company (NYSE: BMY) by 20.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fun
